《大行報告》大和:長汽(02333.HK)推出哈弗H6 PHEV插電混能版標誌轉移至新能源車 相信將成H6及未來哈弗車型銷量催化劑
大和發表報告指,長城汽車(02333.HK)推出哈弗H6 PHEV插電混能版標誌轉移至新能源車領域 相信將成H6及未來哈弗車型銷量催化劑,對長汽向新能源車轉型持積極態度,重申「買入」評級,並預計第三季銷售量恢復將成為未來幾季的股價催化劑,目標價維持28元。
該行指,長汽於7月終止歐拉黑貓和白貓銷售,並計劃在下半年推出閃電貓、朋克貓等車型,及7月起交付芭蕾貓,預計歐拉品牌今年的總銷量為17萬輛。而即將推出的哈弗H6 PEHV和WEY PEHV車型將進一步鞏固公司在中國電動車市場的市場份額。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.